Subscribe

Viewpoint

DOI: 10.4244/EIJ-D-24-00335

Recyclable and contaminated waste from cardiac procedures: a call to action for a sustainable catheterisation laboratory and operating theatre

Haitham Amin1, MD, FSCAI, FACC, FRCPC; Nooraldaem Yousif1, MD, FRCP, FESC, FACC; Thomas F. Lüscher2,3,4, MD, FRCP, FESC, FACC

Globally, healthcare produces 4% to 5% of the greenhouse gas (GHG) emissions, with a predicted 3-fold increase by 20501. The exponential growth of medical waste contributes to global carbon emissions and poses a significant challenge to environmental sustainability2. Hospitals contribute disproportionately to a substantial carbon footprint, especially in energy intensive areas such as radiology suites, operating rooms, and cardiac catheterisation laboratories (CCLs). The number of cardiac procedures worldwide is increasing, with expanding medical facilities to cater for a growing population. Scarce attention has been given to quantifying and reducing waste from CCLs and cardiac operating theatres (COTs) to help lower the carbon footprint3.

Our CCLs and COTs have a routine waste management protocol in place: all contaminated waste gets collected in designated “yellow” bags, gets shredded, autoclaved, and then placed in disposal bags that go to landfills. Incineration of contaminated waste is another disposal route. Non-contaminated waste including paper, plastics, and cardboard boxes (packaging from balloon catheters, stents, guides etc.) are collected in “green” bags. All this potentially recyclable waste goes to landfills due to the lack of an established recycling programme.

A considerable quantity of waste is produced by invasive cardiac procedures, with increasing amounts generated as the procedural complexity rises, dictated by patient characteristics and comorbidities. We have noticed the least amount of waste with diagnostic angiography, followed incrementally by percutaneous coronary interventions (PCIs) and then more complex PCI involving intravascular imaging and plaque modification techniques. Chronic total occlusion PCI produces the largest amount of PCI-related waste. The highest volumes among all cardiac procedures at our institution are produced during structural interventions and coronary artery bypass graft surgeries, with valve repair or replacement.

The amount of cardiac procedure-related waste in our daily practice can be extrapolated to all CCL and COT procedures performed globally (roughly 5 million CCL procedures, including 250,000 transcatheter aortic valve replacements and 1.3 million COT procedures annually)4. This indicates that an enormous amount of waste is produced worldwide, of which a sizeable amount is potentially recyclable. Few studies have attempted to quantify the amount of waste that is produced from cardiac procedures. Doshi et al2 quantified the amount of recyclable waste and noted more recyclable waste with a PCI (1.4 kg) compared to a diagnostic right heart study (0.7 kg). A Stanford team noted 15% recyclable waste per procedure, which would amount to 12 tonnes of material diverted from landfills annually5.

Sustainability is an important issue that requires prompt attention, new learning and swift action from all interventionists and cardiac surgeons. Defining the problem, its causes, and potential solutions are the first steps in this process. Sustainability means taking measures to reduce carbon emissions and other gases that result in global warming and climate change, reducing material consumption, conserving resources, and improving waste management. Carbon dioxide (CO2), nitrous oxide, methane and fluorinated gases are GHGs that leave a climate footprint that is measured in CO2 equivalent (CO2e). The global healthcare sector produces 2 gigatonnes of CO2e annually, equivalent to 4.4% of the net global emissions, and ranks as the 5th largest emitting entity on the planet. As a perspective, this is equivalent to 514 coal-fired powerplants GHG emissions over a year. The USA, China and the EU are responsible for more than half of this carbon footprint1.

The sources of the healthcare climate footprint arise from 3 scopes. Scope 1 refers to direct emissions from healthcare facilities (HCFs), accounting for one-fifth of GHGs. Scope 2 is indirect emissions from purchased energy sources used to run HCFs (one-tenth of GHGs). Scope 3 refers to the healthcare supply chain involved in production, transport, use, and disposal of goods required by HCFs, including food, hospital equipment, medications, instruments, and medical devices. This carbon-intensive supply chain accounts for three-quarters of the GHG emissions. Up to one-quarter of scope 3 emissions are produced overseas by external supply chains. Agriculture and food provision, pharmaceuticals, and transport account for 9%, 5%, and 7%, respectively, of the GHG emissions. Waste management, including incineration or autoclaving of contaminated waste, and healthcare solid waste that finds its way to landfills, accounts for 3% of the GHG emissions. Lastly, metered dose inhalers used in asthma, which have hydrofluorocarbons as propellants, and the anaesthetic gases, which use nitrous oxide and fluorinated gases, account for 1% of the healthcare GHG emissions. Overall, fossil fuel consumption accounts for half of the carbon footprint across all measured scopes1.

Several countries have taken steps to lower healthcare emissions with the Paris Agreement goal of achieving net zero emissions by 2050. This demands decarbonisation across all 3 scopes, transition to renewable energy, and an emphasis on the healthcare supply chain, with engagement of suppliers and manufacturers for low carbon procurement of products and operations. “Reduce, reuse, and recycle” are applicable for implementation in all cardiac services3.

1. Reduce wastage by removing non-essential items included in procedural kits. Avoid “opened but not used” items, loss of expired items due to inventory mismanagement, and water and paper wastefulness. Replace diagnostic angiography with computed tomography angiography or ischaemia testing if indicated. A repository of near-expiry items for preferential use helps to avoid wastage.

2. Reuse items that are safe to resterilise after appropriate infection control clearance. Sterile single-use items, such as catheters, balloons, manifolds, and syringes, cannot be reused, but many metal instruments and plastic bowls are reusable. Reusable blood pressure cuffs and pulse-oximeters are also preferred.

3. Recycle 100% of the uncontaminated paper, plastic, and cardboard boxes from cardiac procedures. There needs to be a streamlined segregation of this recyclable waste and an appropriate waste management strategy that diverts these materials away from landfills.

Implementing these practical principles is the first step in our goal towards sustainable cardiac services in the catheterisation laboratory and the operating theatre.

More studies are needed to quantify the volume of contaminated waste, the amount of recyclable waste, and the impact of recycling as it pertains to invasive cardiac procedures. A cost-effective recycling strategy for uncontaminated waste would decrease landfills and GHG emissions. Establishing a CCL and COT sustainability team, with baseline waste audits and the identification of ways to implement the “reduce, reuse and recycle” mantra are practical steps that we can all take to help our planet.

Patience with small details makes perfect a large work, like the universe.” Rumi.

Conflict of interest statement

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I4A71 Aug 19, 2014
Innovations: resetting our thinking to solve problems
Serruys PW
free

10.4244/EIJV9I2A28 Jun 28, 2013
Numbers needed to treat (lives!) and numbers needed to save (money)
Ribichini F et al
free

Editorial

10.4244/EIJ-E-25-00023 May 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T and Cayla G
free

Editorial

10.4244/EIJ-E-24-00067 Jan 20, 2025
Myval transcatheter heart valve system: a new TAVI contender and remaining uncertainties
Windecker S and Tomii D
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
3 What are the benefits of implementing a streamlined recycling strategy for uncontaminated waste from cardiac procedures?
4 Why is the establishment of sustainability teams in catheterization laboratories and operating theaters important?
8 What are some examples of reusable items mentioned in the article that can be resterilized for use in cardiac procedures?
10 What are the potential benefits of a repository of near-expiry items for preferential use in cardiac procedures?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved